General Info

Established in 2004, Emcure Pharmaceuticals USA Inc. specializes in manufacturing active pharmaceutical ingredient (API), formulation research/development and formulation manufacturing. Located in East Brunswick, N.J., the company s manufacturing capabilities include formulations for BCS (Biopharmaceutics Classification System) drugs, controlled release and extended release drugs. It also provides various solid-oral dosage forms, such as soft gels, tablets and capsules, dry blending, wet granulation, dry granulation, high-speed tablet presses and encapsulation machines. Emcure Pharmaceuticals USA, INC. is a subsidiary of Emcure Pharmaceuticals Limited.